



Abstract— Extracorporeal CO2 Removal device is used in 
clinics when a patient suffers from a pulmonary insufficiency 
like Acute Respiratory Distress Syndrome and allows to 
decarboxylate blood externally. In this work, a model of the 
respiratory system coupled with such a device is proposed to 
analyze the decrease of CO2 partial pressure in blood. To 
validate the model, some parameters are estimated thanks to 
experimental data. Metabolism is a crucial parameter and we 
show that its time evolution must be taken into account in order 
to have correct CO2 partial pressure simulations in arteries and 
in veins. 
I. INTRODUCTION 
Acute Lung Injuries (ALI) or Acute Respiratory Distress 
Syndrome (ARDS) are still life threatening despite new 
strategies in mechanical ventilations [1,2,3]. In a clinical 
environment, a patient with ARDS is typically ventilated 
with low tidal volumes (6ml/kg) and a driving pressure 
(maximal pressure) below 30 cmH2O. This technique, named 
as protective ventilation strategy, is important to reduce 
ventilator-induced lung injuries [4]. To increase the oxygen 
partial pressure, high inspiratory fraction of O2 is used and 
positive end-expiratory pressure (PEEP) allows to open 
alveoli. However, because of the low tidal volumes, the CO2 
partial pressure is not sufficiently reduced, leading to 
hypercapnic acidosis, a deleterious condition for the global 
physiology including the lung and the pulmonary circulation. 
Indeed, hypercapnic acidosis induces pulmonary vaso-
constriction and, consequently, pulmonary hypertension. 
Moreover, pulmonary hypertension can have severe 
repercussions on the right ventricle because of its high 
sensitivity to changes in pulmonary hemodynamics [5,6]. For 
these reasons, pulmonary hypertension and hypercapnic 
acidosis must be strictly controlled. In the case of 
hypertension, the driving pressure and the PEEP can be 
adapted on the ventilator [6]. For hypercapnic acidosis, a 
veno-venous ExtraCorporeal Membrane Oxygenator (vv-
ECMO) is often used. When ARDS is not too severe 
(PaO2/FIO2 > 100 mmHg [7], where PaO2 is the arterial 
partial pressure in O2 and FIO2 is the inspired oxygen 
fraction), the aim of the strategy is to decrease the CO2 partial 
pressure without being too invasive. In this case, the ECMO 
must rather be considered as a low flow extracorporeal CO2 
removal device (ECCO2RD, see Figure 1). 
To improve the knowledge and treatment of ARDS in 
intensive care patients, mathematical models of the 
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respiratory system can be helpful in providing tools to 
characterize the gas exchanges efficiency in the lungs and in 
the ECCO2RD.  
The aim of the present work is to develop such a model, 
simple enough to be solved in real-time in a clinical 
environment. Our model is derived from the works of Batzel 
et al. [8] and Karbing et al. [9].  A pulmonary shunt is taken 
into account in parallel with the lungs and the modelling of 
the ECCO2RD consists in adding a second "lung 
compartment", which is perfused by a fraction of the 
systemic blood flow extracted in the inferior vena cava and 
reinjected in the atrium, after crossing the device (see Figure 
1). 
Figure 1.  Extracorporeal CO2 removal device (ECCO2RD). RA is the right 
atrium and IVC is the inferior vena cava. Figure adapted from M.J. Murray 
and D.J. Cook [10].  
We estimate the parameters of the model and emphasize 
the role of the metabolism whose value cannot be assumed 
constant during our experiments. Taking into account its 
variations, we show that our model provides a good 
description of the CO2 time evolution and can thus be 
considered as an interesting tool that could help clinicians to 
improve the use of ECCO2RD. 
II. METHODS 
In this study, the respiratory system assisted by an 
ECCO2RD is reduced to a small number of "compartments" 
(lumped parameter model). We consider two compartments 
for the respiratory system: the lung and the tissues. In 
addition, a third compartment is added to model the 
ECCO2RD (see Figure 2). 
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Figure 2.  Respiratory model assisted by an ECCO2RD. The symbols fS 
and fd are respectively the pulmonary shunt fraction and the fraction of 
cardiac blood flow (QC) which crosses the ECCO2RD. The symbols Ca,i , 
Cv,i , Cd,i , Crv,i and Cl,i denote respectively the blood concentrations for 
component i in arteries, in veins, after the ECCO2RD, in the right ventricule 
and in the lung. 
A. Model of the respiratory system 
Our mathematical model of pulmonary gas exchanges and 
tissues gas exchanges is based on the work of Batzel et al. 
[8]. This model considers that diffusion of O2 and CO2 
through the alveolar-capillary membrane is fast so that 
equilibrium can be assumed between the alveoli and the 
capillaries at the end of pulmonary capillaries. To include 
pulmonary gas exchanges abnormalities, additional 
parameters and additional equations are required. ARDS is a 
complex phenomenon and some authors describe this 
pathology by dividing the lung into 2 compartments to model 
ventilation/perfusion mismatch [9,11]. Since the identifi-
cation of the parameters of these 2 compartments is not easy 
(and even impossible in our case with the available 
experimental data), we will use a simpler description. A 
pulmonary shunt and a dead volume will be used whose 
importance will determine the global quality of gas 
exchanges and which will thus allow to model lung injuries 
in a simple way. In the tissues, O2 is consumed and CO2 is 
produced by the metabolism and these quantities are 
considered as parameters of our model. Different estimations 
of these parameters are possible and will be presented below. 
B. Model of the ECCO2RD 
The ECCO2RD is considered as a second lung 
compartment which takes a fraction of the systemic blood 
flow in the inferior vena cava and rejects the corresponding 
treated blood flow in the right atrium (see Figure 1).  
However, it is important to mention that the diffusion of O2 
and CO2 across the synthetic membrane of the device is 
much slower than across the lung membrane. For this 
reason, the equilibrium between the gas and the blood in the 
device is usually not reached. Therefore, we have to model 
the diffusion of O2 and CO2 between the gas and the blood 
across the synthetic membrane [12]. We assume that the 
flows of air and blood are one-dimensional but have 
opposite directions (see Figure 3 and see for instance [13]).   
Figure 3.  ECCO2RD model
 
C. Blood chemistry model  
In the blood, the relationships between partial pressures 
and total concentrations of gases are really complex. Indeed, 
O2 is dissolved in blood plasma and also complexed with 
hemoglobin while CO2 is dissolved in blood plasma, 
complexed with hemoglobin and subject to the hydratation 
reaction which couples CO2 and HCO3–. Since the CO2 
partial pressure can vary very significantly, especially when a 
protective ventilation is used and when the medical device is 
switched on, we must consider the influence of the pH in 
blood plasma over the O2 haemoglobin saturation curve. To 
take this into account in our approach, the relation between 
the O2 concentration and the O2 partial pressure is based on 
the work of Grodins et al. [14]. The relations between CO2 
concentration, pH in plasma and CO2 partial pressure are 
based on the work of Trueb et al. [15]. 
D. Estimations of CO2 production and O2 consumption by 
the metabolism 
In a stabilized situation, the CO2 production (MRCO2) can 
be estimated by:  
 MRCO2 = Qc (Cv,CO2 – Ca,CO2), (7) 
where Qc is the cardiac output, Cv,CO2 and Ca,CO2 are 
respectively the total venous and arterial CO2 concentrations 
(the venous concentration is measured in the inlet cannula of 
the ECCO2RD). The O2 production (MRO2) can be 
determined similarly. Another estimation is possible by 
analyzing the gas expired out the ECCO2RD and gas expired 
out the ventilator : 
 MRCO2 = QD FD,CO2 + QL FE,CO2, (8) 
where  
• FD,CO2 and FE,CO2 are respectively the CO2 expired 
volume fraction out the ECCO2RD device and the 
volume fraction of end tidal CO2. 
• QL = Fr (VT – VD) is the mean alveolar ventilation 
rate. VT is the tidal volume, Fr is the respiratory 
frequency and VD is the dead volume. For computing 
MRCO2, we assume that VD = 0.3 VT [16].  
In our experimental setup, the O2 fractions in the ventilator 
and in the extracorporeal device are not available. 
Consequently, we will assume that MRO2 is equal to MRCO2. 
Finally, note that standard rough estimations of CO2 
production and O2 consumption can also be found in the 
literature with values around 7ml/min/kg [17]. 
E. Experimental data 
Experiments were carried out on 6 pigs, with the approval 
of the Ethics Committee of the Medical Faculty of the 
University of Liège. Protective ventilation was introduced for 
the pigs and extracorporeal CO2 removal was used to 
decarboxylate the blood. Note that no true pulmonary 
insufficiencies were induced on the animals but adjustment of 
the parameters of the protective ventilation allows to mimic 
the impaired gas exchanges that take place in such situations.   
Blood flow was measured with thermodilution technique 
(PiCCO®, Pulsion, Germany) and with an admittance 
pressure-volume catheter (Transonic, USA). Tidal volume, 
  
 
PEEP, FI,O2, respiratory frequency and driving pressure were 
fixed by the ventilator. Arterial and venous blood samples 
were analyzed with a RapidPoint500® (Siemens, Germany) 
during basal state, after the introduction of the protective 
ventilation and during the CO2 removal procedure. In our 
experiments, the blood flow through the extracorporeal 
device was successively set to 200, 400 and 600 ml/min, 
which is referred to as ECCO2RD 200, ECCO2RD 400 and 
ECCO2RD 600 in Figures 4 and 5. 
Thanks to cardiac blood flow measurements, to analyses 
of blood samples in the arteries and given the parameters 
fixed by the ventilator, the pulmonary shunt can be estimated 
just before the ECCO2RD is switched on and we consider its 
value constant for the whole simulation. 
III. RESULTS AND DISCUSSION 
The results corresponding to 4 pigs are presented and 
discussed in this section. For the other 2 pigs, experimental 
issues occurred (cardiac arrest for pig 1 and blood clots in 
the cannula for pig 6), which made the analysis impossible 
in these cases.  
A. Metabolism determination 
For all pigs, some blood estimations of MRCO2 obtained 
from equation 7, and similar estimations of MRO2, were too 
low to be physiological (below 0.05 l/min) and their values 
vary a lot for a same experimental state. On the other hand, 
gas estimations of MRCO2 obtained from equation 8 were 
more stable and their values were always in a physiological 
range. For these reason, only equation 8 will be used from 
now on to characterize the evolution of metabolism. Figure 4 
corresponds to pig 5 and describes the production of CO2 by 
metabolism as a function of time. This production decreases 
linearly, with a slope of 7•10-4 l/min2. Note also that since 
pig 5 weighs 29 kg, and considering a standard specific 
metabolism production of 7ml/min/kg [19], a rough 
estimation of its MRCO2 (=MRO2) is around 0.203 l/min, 
which is actually the order of magnitude of the experimental 
values given in Figure 4. For the other pigs, the results are 
similar to Figure 4 (a decrease of MRCO2 around 7.10-4 l/min2 
and an initial value of MRCO2 around 0.27 l/min). Finally let 
us mention that the decrease of metabolism in our 
experimental setting after switching on the ECCO2RD is 
probably mainly due to hypothermia induced by the absence 
of a heater in our device (see the example in Figure 4). 
Figure 4.  The MRCO2 estimations and the decrease of temperature for the 
pig 5 
B. Result of the model and comparison with experiments 
Using the values of CO2 production and O2 consumption 
given in the previous section and taking into account the 
influence of the ECCO2RD, our model allows to determine 
the time evolution of the gas concentrations in the blood for 
pigs 2 to 5. The corresponding results are presented in 
Figure 5, which shows the calculated curves describing the 
decrease of CO2 partial pressure in arteries and in veins. The 
figure also shows the corresponding experimental points 
(crosses). The solid lines correspond to time varying 
metabolims, while the dotted lines were obtained by 
considering constant CO2 gas production and constant O2 
consumption rates. These constant rates can be estimated by 
MRO2 = MRCO2 = W•7•10-3 l/min, where W is the weight of 
the pig. It is then interesting to note that the obtained values 
are found to be close to the corresponding mean measured 
values. The comparison of the solid and dotted lines with the 
experimental results clearly shows that a much better model 
is obtained when the time variations of metabolism are taken 
into account. This is particularly true at the most left and 
right parts of the 4 panels of Figure 5, since at these times, 
the metabolism production rates for the 2 simulations are 
quite different from each other.  
IV. CONCLUSION  
In this work, we have built and validated a mathematical 
model of the respiratory system assisted by an 
extracorporeal CO2 removal device. The predictions of the 
model are shown to be in good agreement with experimental 
data provided that the time evolutions of CO2 production and 
O2 consumption by metabolism are taken into account. The 
time evolution of metabolism must thus be described 
carefully in models of the respiratory system assisted by 
extracorporeal devices. 
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Figure 5.  Time evolution of calculated (curves) and measured (crosses) CO2 partial pressures in veins and in arteries for pigs 2 to 5. Solid and dotted lines 
correspond respectively to time varying and constant metabolisms (symbols var. MR and cst. MR).  
 
